Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population
Crossref DOI link: https://doi.org/10.1007/s40261-017-0530-3
Published Online: 2017-04-27
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peckham, Alyssa M.
Fairman, Kathleen A.
Sclar, David A.
License valid from 2017-04-27